We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
+4.01%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$21.4B
AUM Growth
+$1.27B
(+6.3%)
Cap. Flow
+$730M
Cap. Flow
% of AUM
3.41%
Top 10 Holdings %
Top 10 Hldgs %
26.79%
Holding
881
New
137
Increased
443
Reduced
202
Closed
30
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AngloGold Ashanti
AU
|
+$259M |
| 2 |
Vale
VALE
|
+$83M |
| 3 |
WPX
WPX Energy, Inc.
WPX
|
+$44.4M |
| 4 |
Gold Fields
GFI
|
+$39.7M |
| 5 |
Royal Gold
RGLD
|
+$35.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MON
Monsanto Co
MON
|
+$109M |
| 2 |
Newmont
NEM
|
+$96M |
| 3 |
B
Barrick Mining
B
|
+$77.1M |
| 4 |
Franco-Nevada
FNV
|
+$63.2M |
| 5 |
GG
Goldcorp Inc
GG
|
+$58M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 50.75% |
| 2 | Energy | 16.94% |
| 3 | Healthcare | 6.45% |
| 4 | Technology | 5.96% |
| 5 | Consumer Staples | 2.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARI
276
Apollo Commercial Real Estate
ARI
$887M
| $6.16M | 0.03% |
336,739
+27,411
| +9% | +$502K |
|
|
BCPC
277
Balchem Corp
BCPC
$5.23B
| $6.15M | 0.03% |
62,683
+2,487
| +4% | +$232K |
|
|
MFA
278
MFA Financial
MFA
$929M
| $6.15M | 0.03% |
202,736
+9,250
| +5% | +$283K |
|
279
Invesco Mortgage Capital
IVR
$776M
| $6.13M | 0.03% |
38,543
+2,459
| +7% | +$399K |
|
280
ConocoPhillips
COP
$147B
| $6.07M | 0.03% |
87,210
+72,531
| +494% | +$4.83M |
|
281
Duke Energy
DUK
$102B
| $6.01M | 0.03% |
75,953
+47,537
| +167% | +$3.66M |
|
282
Chevron
CVX
$388B
| $5.99M | 0.03% |
47,337
+23,600
| +99% | +$2.93M |
|
283
Peabody Energy
BTU
$2.78B
| $5.93M | 0.03% |
130,412
+8,838
| +7% | +$362K |
|
284
Nucor
NUE
$56.4B
| $5.85M | 0.03% |
93,632
-26,427
| -22% | -$1.69M |
|
285
ArcelorMittal
MT
$50.4B
| $5.74M | 0.03% |
199,400
-45,665
| -19% | -$1.52M |
|
286
Ionis Pharmaceuticals
IONS
$9.35B
| $5.7M | 0.03% |
136,696
+21,510
| +19% | +$954K |
|
|
LADR
287
Ladder Capital
LADR
$1.25B
| $5.69M | 0.03% |
364,539
+35,605
| +11% | +$536K |
|
288
First Solar
FSLR
$21.8B
| $5.67M | 0.03% |
107,774
-936
| -0.9% | -$61.2K |
|
|
X
289
DELISTED
US Steel
X
| $5.64M | 0.03% |
162,394
-42,288
| -21% | -$1.51M |
|
290
AT&T
T
$165B
| $5.55M | 0.03% |
+228,721
| New | +$5.74M |
|
|
BLUE
291
DELISTED
bluebird bio
BLUE
| $5.51M | 0.03% |
2,709
+282
| +12% | +$643K |
|
292
Reliance Steel & Aluminium
RS
$20.8B
| $5.48M | 0.03% |
62,630
-21,766
| -26% | -$1.98M |
|
293
POSCO
PKX
$15.8B
| $5.46M | 0.03% |
73,694
-16,501
| -18% | -$1.34M |
|
|
CYS
294
DELISTED
CYS Investments Inc.
CYS
| $5.46M | 0.03% |
727,425
+25,188
| +4% | +$180K |
|
295
Gerdau
GGB
$9.44B
| $5.45M | 0.03% |
1,940,410
+8,549
| +0.4% | +$29.8K |
|
296
Wolfspeed
WOLF
$1.2B
| $5.39M | 0.03% |
129,786
-1,129
| -0.9% | -$49.4K |
|
297
Devon Energy
DVN
$51.9B
| $5.28M | 0.02% |
120,147
-2,496
| -2% | -$96.7K |
|
298
BlackRock TCP Capital
TCPC
$265M
| $5.24M | 0.02% |
362,437
+5,862
| +2% | +$85.1K |
|
299
Alkermes
ALKS
$8.82B
| $5.2M | 0.02% |
126,272
+5,629
| +5% | +$256K |
|
300
Goldman Sachs BDC
GSBD
$975M
| $5.19M | 0.02% |
253,565
+4,322
| +2% | +$86.8K |
|
Similar funds
DAM
VanEck Associates's Q2 2018 Portfolio in Review
As of Q2 2018, VanEck Associates held 881 positions worth $21.4B, up 6.3% from $20.1B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
VanEck Associates deployed $730M of net new capital in Q2 2018, opening 137 new positions and adding to 443 existing holdings. Its largest new stake was Colgate-Palmolive: 345,613 shares worth $22.4M.
By sector, the portfolio is most concentrated in Materials at 51% of assets, down from 52% a quarter earlier, followed by Energy and Healthcare.
On the sell side, the largest reduction was Newmont, an estimated $96M trimmed.
- VanEck Associates's largest Q2 2018 buy was Colgate-Palmolive: 345,613 shares worth $22.4M.
- VanEck Associates added most to AngloGold Ashanti in Q2 2018, an estimated $259M increase.
- VanEck Associates's biggest Q2 2018 reduction was Newmont, cutting an estimated $96M.
- VanEck Associates fully exited Monsanto Co in Q2 2018, selling an estimated $109M.
- VanEck Associates's ten largest holdings make up 27% of its $21.4B portfolio in Q2 2018.
- VanEck Associates opened 137 new positions and closed 30 in Q2 2018.
- VanEck Associates's portfolio value rose 6.3% quarter-over-quarter to $21.4B.
Based on VanEck Associates's 13F filing for Q2 2018, filed 13 Aug 2018.